Canada Covid Vaccine Agreements

Canada Covid Vaccine Agreements: A Breakdown

As the world continues to grapple with the Covid-19 pandemic, vaccines are seen as the key to eventual recovery. Countries around the globe are making arrangements to secure doses of the vaccine once it becomes available. Canada is no exception. In this article, we will delve into the agreements made by the Canadian government in their quest to secure vaccine doses for their citizens.

The Canadian government has made arrangements with several pharmaceutical companies to ensure that Canadians have access to various vaccines when it becomes available. Here is a breakdown of the agreements:

1. Pfizer-BioNTech

The Canadian government secured a deal with Pfizer-BioNTech for up to 76 million doses of their Covid-19 vaccine. The agreement also includes the option to purchase an additional 38 million doses. The vaccine has been approved by Health Canada and is currently being administered to Canadians across the country.

2. Moderna

Canada has also secured an agreement with Moderna for up to 44 million doses of their Covid-19 vaccine. The agreement also includes the option to purchase an additional 16 million doses. The vaccine has also been approved by Health Canada and is currently being administered to Canadians.

3. AstraZeneca

Canada has made an agreement with AstraZeneca for up to 20 million doses of their Covid-19 vaccine. The vaccine has yet to be approved by Health Canada, but the approval process is underway.

4. Johnson & Johnson

The Canadian government has also secured an agreement with Johnson & Johnson for up to 38 million doses of their Covid-19 vaccine. The vaccine has yet to be approved by Health Canada, but the approval process is underway.

5. Novavax

Canada has also secured an agreement with Novavax for up to 76 million doses of their Covid-19 vaccine. The vaccine has yet to be approved by Health Canada, but the approval process is underway.

6. COVAX

Canada has also joined the global effort to ensure equitable access to the Covid-19 vaccine through COVAX. COVAX is a global initiative aimed at ensuring equitable access to Covid-19 vaccines. Canada has pledged $440 million to COVAX, which will provide vaccine doses to low- and middle-income countries.

In conclusion, Canada has secured agreements with several pharmaceutical companies to ensure that Canadians have access to various Covid-19 vaccines. The vaccine rollout is currently ongoing across the country, and the government continues to work towards securing more vaccines to meet the needs of its citizens. It is important to note that the vaccine remains a critical tool in the fight against Covid-19, and Canadians are encouraged to get vaccinated when it becomes available to them.